Buffalo, NY, United States of America

Rachel Evans

This inventor holds 1 USPTO granted patent. Top assignees: Centro De Inmunologia Molecular, Innovative Immunotherapy Alliance, S.A.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel Evans. Retrieved from https://idiyas.com/inventor/rachel-evans-hbjk137g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachel Evans - Innovator in Therapeutic Compositions

Introduction

Rachel Evans is a notable inventor based in Buffalo, NY (US). She has made significant contributions to the field of therapeutic compositions, particularly in the treatment of tumors of epithelial origin. Her innovative work has the potential to impact many patients suffering from these conditions.

Latest Patents

Rachel holds a patent titled "Use of Therapeutic Compositions for the Treatment of Patients with Tumors of Epithelial Origin." This patent represents her commitment to advancing medical treatments and improving patient outcomes. She has 1 patent to her name, showcasing her dedication to innovation in healthcare.

Career Highlights

Throughout her career, Rachel has worked with various organizations that focus on immunotherapy and molecular biology. Notably, she has been associated with Innovative Immunotherapy Alliance, S.A. and Centro De Inmunologia Molecular. These experiences have enriched her expertise and contributed to her success as an inventor.

Collaborations

Rachel has collaborated with Tania Crombet Ramos, a fellow professional in the field. Their partnership highlights the importance of teamwork in driving innovation and achieving breakthroughs in therapeutic research.

Conclusion

Rachel Evans is a pioneering inventor whose work in therapeutic compositions is making a difference in the medical field. Her contributions and collaborations reflect her commitment to improving treatment options for patients with tumors of epithelial origin.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…